最高ROE — Healthcare
股本回报率衡量公司利用股东权益创造利润的效率。
共 445 家公司有ROE数据。
按ROE排名(445)
| # | 代码 | 名称 | 市值 | ROE |
|---|---|---|---|---|
| 1 | CL | COLGATE-PALMOLIVE COMPANY | $79.5B | 1362.7% |
| 2 | HALO | HALOZYME THERAPEUTICS, INC. | $8.2B | 649.2% |
| 3 | RIGL | RIGEL PHARMACEUTICALS, INC. | $631M | 531.8% |
| 4 | DBVT | DBV TECHNOLOGIES S.A. | $1.2B | 416.0% |
| 5 | CLX | THE CLOROX COMPANY | $15.4B | 252.3% |
| 6 | CSBR | CHAMPIONS ONCOLOGY, INC. | $83M | 124.6% |
| 7 | MEDP | Medpace Holdings, Inc. | $12.8B | 98.3% |
| 8 | AMGN | AMGEN INC | $209.2B | 89.1% |
| 9 | KLAC | KLA CORP | $199.8B | 86.6% |
| 10 | NRC | National Research Corporation | $304M | 79.2% |
| 11 | LLY | ELI LILLY AND COMPANY | $992.4B | 77.8% |
| 12 | MMM | 3M COMPANY | $87.1B | 69.1% |
| 13 | IDXX | IDEXX LABORATORIES INC /DE | $52.4B | 66.0% |
| 14 | CON | CONCENTRA GROUP HOLDINGS PARENT, INC | $3.1B | 60.4% |
| 15 | PMCB | PHARMACYTE BIOTECH, INC. | $7M | 59.1% |
| 16 | ADMA | ADMA BIOLOGICS, INC. | $3.7B | 56.6% |
| 17 | THC | TENET HEALTHCARE CORP | $20.8B | 56.1% |
| 18 | SEE | SEALED AIR CORP/DE | $6.2B | 42.4% |
| 19 | EW | EDWARDS LIFESCIENCES CORPORATION | $50.2B | 41.8% |
| 20 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | $44.2B | 39.8% |
| 21 | BMY | BRISTOL-MYERS SQUIBB COMPANY | $127.0B | 38.2% |
| 22 | MRK | Merck & Co., Inc. | $306.1B | 37.0% |
| 23 | EXEL | EXELIXIS, INC. | $11.4B | 36.2% |
| 24 | WAT | WATERS CORP /DE/ | $31.3B | 34.9% |
| 25 | WDFC | WD-40 COMPANY | $3.2B | 33.9% |
| 26 | JNJ | Johnson & Johnson | $598.7B | 32.9% |
| 27 | ILMN | Illumina, Inc. | $20.6B | 31.2% |
| 28 | ACAD | ACADIA PHARMACEUTICALS INC. | $4.2B | 30.9% |
| 29 | PG | PROCTER & GAMBLE CO | $388.6B | 30.6% |
| 30 | DXCM | DEXCOM, INC. | $28.3B | 30.5% |
| 31 | MTEX | MANNATECH INC | $13M | 28.9% |
| 32 | LNTH | LANTHEUS HOLDINGS, INC. | $5.0B | 28.7% |
| 33 | SLSN | SOLESENCE, INC. | $90M | 28.3% |
| 34 | LFVN | LIFEVANTAGE CORP | $59M | 28.3% |
| 35 | GYRE | Gyre Therapeutics, Inc. | $794M | 28.3% |
| 36 | SIGA | Siga Technologies INC | $463M | 27.4% |
| 37 | UG | UNITED-GUARDIAN, INC. | $31M | 27.4% |
| 38 | CHE | CHEMED CORPORATION | $5.8B | 27.0% |
| 39 | HIMS | HIMS & HERS HEALTH, INC. | $3.3B | 26.4% |
| 40 | ULS | UL Solutions Inc. | $16.9B | 25.8% |
| 41 | INCY | INCYTE CORPORATION | $20.2B | 24.9% |
| 42 | PDEX | PRO-DEX, INC. | $142M | 24.5% |
| 43 | ECL | ECOLAB INC. | $86.9B | 24.1% |
| 44 | SBC | SBC Medical Group Holdings Incorporated | $396M | 23.9% |
| 45 | RPM | RPM International Inc. | $14.6B | 23.9% |
| 46 | RMD | ResMed Inc. | $37.3B | 23.5% |
| 47 | IRMD | IRADIMED CORPORATION | $1.3B | 22.2% |
| 48 | IPAR | INTERPARFUMS, INC. | $3.2B | 22.1% |
| 49 | EHC | Encompass Health Corporation | $10.8B | 22.0% |
| 50 | MDXG | MIMEDX GROUP, INC. | $724M | 22.0% |
| 51 | CBT | Cabot Corporation | $4.0B | 21.4% |
| 52 | OPXS | OPTEX SYSTEMS HOLDINGS, INC. | $90M | 21.2% |
| 53 | VRTX | VERTEX PHARMACEUTICALS INC / MA | $126.2B | 21.2% |
| 54 | IQV | IQVIA HOLDINGS INC. | $30.3B | 20.9% |
| 55 | CORT | CORCEPT THERAPEUTICS INC | $3.8B | 20.8% |
| 56 | HAE | HAEMONETICS CORPORATION | $2.9B | 20.4% |
| 57 | MSA | MSA SAFETY INCORPORATED | $7.6B | 20.4% |
| 58 | GEHC | GE HEALTHCARE TECHNOLOGIES INC. | $38.4B | 20.1% |
| 59 | PPG | PPG INDUSTRIES, INC. | $27.6B | 19.8% |
| 60 | A | Agilent Technologies, Inc. | $34.3B | 19.3% |
| 61 | MD | Pediatrix Medical Group, Inc. | $1.7B | 19.1% |
| 62 | INSP | Inspire Medical Systems, Inc. | $1.8B | 18.6% |
| 63 | ARDT | Ardent Health, Inc. | $1.3B | 18.6% |
| 64 | UTHR | United Therapeutics Corporation | $21.7B | 18.5% |
| 65 | CHD | CHURCH & DWIGHT CO., INC. | $24.8B | 18.4% |
| 66 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | $39.4B | 17.8% |
| 67 | KEQU | KEWAUNEE SCIENTIFIC CORPORATION | $119M | 17.7% |
| 68 | ELMD | ELECTROMED, INC. | $196M | 17.4% |
| 69 | UFPT | UFP Technologies, Inc. | $1.6B | 17.2% |
| 70 | UHS | UNIVERSAL HEALTH SERVICES, INC. | $12.9B | 17.1% |
| 71 | NL | NL INDUSTRIES, INC. | $302M | 16.9% |
| 72 | PAHC | Phibro Animal Health Corporation | $2.2B | 16.9% |
| 73 | KRYS | KRYSTAL BIOTECH, INC. | $8.1B | 16.8% |
| 74 | PODD | INSULET CORPORATION | $17.4B | 16.3% |
| 75 | SOLV | SOLVENTUM CORPORATION | $12.9B | 16.2% |
| 76 | ISRG | Intuitive Surgical, Inc. | $178.8B | 16.0% |
| 77 | WST | WEST PHARMACEUTICAL SERVICES, INC. | $18.3B | 15.5% |
| 78 | TMDX | TransMedics Group, Inc. | $5.0B | 15.5% |
| 79 | ENSG | Ensign Group, Inc | $12.4B | 15.4% |
| 80 | SRPT | SAREPTA THERAPEUTICS, INC. | $1.8B | 15.4% |
| 81 | OPCH | OPTION CARE HEALTH, INC. | $5.2B | 15.1% |
| 82 | NBIX | NEUROCRINE BIOSCIENCES, INC. | $13.3B | 14.7% |
| 83 | SYK | STRYKER CORP | $148.3B | 14.5% |
| 84 | REGN | REGENERON PHARMACEUTICALS, INC. | $82.6B | 14.4% |
| 85 | CDNA | CAREDX, INC. | $965M | 13.9% |
| 86 | JAZZ | Jazz Pharmaceuticals plc | $11.7B | 13.7% |
| 87 | LMAT | LEMAITRE VASCULAR, INC. | $2.5B | 13.1% |
| 88 | PGNY | Progyny, Inc. | $1.5B | 12.9% |
| 89 | DGX | Quest Diagnostics Inc | $23.4B | 12.9% |
| 90 | DTIL | Precision BioSciences, Inc. | $101M | 12.7% |
| 91 | ABT | Abbott Laboratories | $202.3B | 12.5% |
| 92 | BCPC | Balchem Corporation | $5.9B | 12.3% |
| 93 | BSX | BOSTON SCIENTIFIC CORPORATION | $114.0B | 11.9% |
| 94 | SRTS | Sensus Healthcare, Inc. | $68M | 11.9% |
| 95 | UTMD | UTAH MEDICAL PRODUCTS, INC. | $212M | 11.8% |
| 96 | CDRE | CADRE HOLDINGS, INC. | $1.8B | 11.6% |
| 97 | HCSG | HEALTHCARE SERVICES GROUP, INC. | $1.5B | 11.6% |
| 98 | HSIC | HENRY SCHEIN INC | $9.7B | 11.5% |
| 99 | SXT | Sensient Technologies Corp | $4.3B | 11.3% |
| 100 | HOLX | HOLOGIC INC | $16.8B | 11.2% |
其他板块 ROE 排名
Source: SEC EDGAR, Polygon.io